Align Technology, Inc. (algn)

ALGN — Company Overview

Align Technology, Inc. (ALGN) is a large-cap company in the Healthcare sector, operating in Medical Instruments & Supplies.

ALGN — Business Description

Align Technology, Inc. (ALGN) operates in Medical Instruments & Supplies within the broader Healthcare market. Align Technology, Inc. provides Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners and services in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers Invisalign comprehensive package to treat adults and teens malocclusion and features, and orthodontic needs of teenage or younger patients; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients between the ages of six and ten years with a mixture of primary/baby and permanent teeth. This segment also provides Invisalign express, Invisalign lite, and Invisalign moderate; Invisalign Go, Invisalign Go express, and Invisalign Go Plus; retention products,…

Official website: https://www.aligntech.com.

ALGN — Investment Thesis

The investment thesis for Align Technology, Inc. (ALGN) rests on how Healthcare dynamics, profitability, and valuation interact at today's price.

• Revenue is expanding at roughly 4.3% year-over-year (public data).
• Trailing P/E of 25.68× sits in a moderate band relative to high-growth peers.
• Forward P/E (11.81×) is below trailing P/E — earnings may be expected to improve.
• Equity market capitalization is approximately $10.53B.

See the free estimates and earnings pages for public targets and growth metrics. Ownership, live news, and deeper models remain in Vest Terminal.

ALGN — Financial Health

Financial health for Align Technology, Inc. (ALGN) is summarized from publicly reported profitability, leverage, and cash-flow metrics.

Profit margin near 10.0% leaves a narrower cushion versus higher-margin peers. Positive free cash flow of $594.11M supports balance-sheet flexibility.

ALGN — Growth Outlook

Growth outlook for Align Technology, Inc. (ALGN) depends on demand trends in Medical Instruments & Supplies and the company's ability to convert revenue into sustainable earnings.

• Revenue growth of 4.3% suggests steady but measured expansion.
• Earnings declined -12.1% year-over-year — margin or volume pressure may be in play.
• Price is 26.1% below the 52-week high.
• Shares trade 21.5% above the 52-week low — limited rebound so far.

ALGN — Competitive Position

Align Technology, Inc. (ALGN) is evaluated against peers on scale, margin structure, and capital efficiency within Healthcare.

• Competes within Healthcare, specifically in Medical Instruments & Supplies.
• Market capitalization of $10.53B places ALGN among large-cap peers.
• Gross margin near 70.7% may reflect pricing power or favorable mix.

ALGN — Summary

Align Technology, Inc. (ALGN) is a large-cap Healthcare company focused on Medical Instruments & Supplies, listed on NMS. Last price $148.17 with market cap $10.53B. Trailing P/E 25.68×. Revenue grew 4.3% year-over-year per public data. Notable strengths include gross margin of 70.7% supports competitive unit economics. Key watch items include earnings decline of -12.1% year-over-year. Public estimates and earnings snapshots for Align Technology, Inc. are on this site; ownership, live news, and deeper models remain in Vest Terminal.